That did happen with PAA and their Orphan Drug Designation from the FDA recently. Mainly based on my BOT/FDA experience, I was expecting it to go down to the last minute of the maximum review period, but they surprised everyone (including management) and the FDA provided ODD a whole month early!
And just an aside - PAA never went into a trading halt either. The FDA posted the ODD approval on their FDA Register during US office hours - so that info was available before the ASX opened, so no trading halt requested. I'm not sure if that could happen in our case - but I imagine it's a possibility.
BOT - Anything but charting, page-8584
-
- There are more pages in this discussion • 2,327 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $671.1M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 37.0¢ | $1.949M | 5.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 163455 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 33207 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |